Cibus (CBUS) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
2 Jun, 2026Opening remarks and agenda
Meeting held virtually to increase access and participation, with board and management present.
Meeting recorded and webcast replay to be made available online.
Agenda included election of directors, executive compensation approval, and auditor ratification.
Board and executive committee updates
Nine incumbent directors nominated for re-election to serve until the next annual meeting.
Interim CEO and CFO present, with board chairman overseeing proceedings.
Shareholder proposals
Three proposals considered: election of directors, advisory vote on executive compensation, and auditor ratification.
No other proposals were properly submitted or considered.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Cibus
- Q3 net loss of $201.5M from goodwill impairment; cost savings and commercialization ongoing.CBUS
Q3 20249 Jul 2026 - Gene editing is transforming agriculture with rapid regulatory acceptance and high-margin royalty models.CBUS
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20248 Jul 2026 - Gene editing accelerates crop innovation and royalty growth as global regulatory support expands.CBUS
LD Micro Main Event XIX Investor Conference8 Jul 2026 - EU regulatory shift accelerates gene editing commercialization and royalty growth prospects.CBUS
Sidoti Small-Cap Virtual Investor Conference17 Jun 2026 - Biotech firm targets $200M in offerings amid liquidity concerns and potential shareholder dilution.CBUS
Registration filing15 May 2026 - Revenue up, net loss down, and cash funds operations into late Q1 2027; more capital needed.CBUS
Q1 202614 May 2026 - Annual meeting covers director elections, executive pay, auditor ratification, and governance policies.CBUS
Proxy filing20 Apr 2026 - Key votes include director elections, executive pay approval, and auditor ratification for 2026.CBUS
Proxy filing20 Apr 2026 - Advanced Rice and ingredient programs, cut costs, and raised funds for 2026 milestones.CBUS
Q4 202517 Mar 2026